TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/23 17:49 | 10/12/23 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agenus Inc | MA | T | P.m | 25 | 1.10 | 0 | 23 | 0 | 21,773 | D | |||||||||||||||
10/6/23 16:26 | 10/4/23 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agenus Inc | MA | T | P | 16 | 1.09 | 0 | 15 | 0 | 21,750 | D | |||||||||||||||
8/31/23 17:53 | 8/29/23 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agenus Inc | MA | T | P | 45 | 1.52 | 0 | 30 | 0 | 21,735 | D | |||||||||||||||
8/28/23 17:15 | 8/24/23 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agenus Inc | MA | T | P.m | 281 | 1.54 | 0 | 183 | 1 | 21,705 | D | |||||||||||||||
5/12/23 17:18 | 5/10/23 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agenus Inc | MA | T | P.m | 67 | 1.47 | 0 | 45 | 0 | 21,640 | D | |||||||||||||||
5/5/23 18:00 | 5/3/23 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Agenus Inc | MA | T | P.m | 260 | 1.04 | 0 | 250 | 1 | 21,595 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |